What you need to know about heart cancer

Credit: Unsplash+

When we hear the word “cancer,” our minds often go to more commonly known types like breast, lung, or skin cancer.

Heart cancer, however, is something most people might never have heard of. It’s rare, mysterious, and can be quite serious.

This article aims to shed some light on heart cancer, its prevalence, and other important aspects.

Cancer occurs when cells in the body grow uncontrollably. While this can happen in almost any part of the body, the heart is an uncommon site for cancer.

The rarity of heart cancer is due, in part, to the heart’s cells. Unlike other parts of the body, the cells in the heart don’t divide and grow as quickly, which means there’s less chance for cancer to develop.

When heart cancer does occur, it’s most often a type called a sarcoma—a cancer that starts in the soft tissues of the body. There are different kinds of sarcomas based on the type of tissue they originate in, but the most common type affecting the heart is called angiosarcoma.

This cancer begins in the cells that line the blood vessels of the heart. Other types of heart cancer include rhabdomyosarcomas, which start in the muscle tissue, and fibrosarcomas, which begin in the connective tissue.

The symptoms of heart cancer can vary widely and might include chest pain, swelling in the legs or abdomen, fatigue, and irregular heart rhythms.

These symptoms are common to many other heart conditions, which can make heart cancer difficult to diagnose early. Imaging tests like echocardiograms, MRIs, and CT scans, along with biopsies, are often needed to confirm a diagnosis.

Given its rarity, you might wonder just how prevalent heart cancer is. It’s believed that primary heart cancers (cancers that start in the heart) occur in about 1 in every 20 million people per year.

To put that into perspective, other types of cancer like lung and breast cancer are hundreds of thousands of times more common. Most heart tumors are actually metastatic cancers, meaning they’ve spread from other parts of the body.

Why is heart cancer so rare? Scientists believe it’s partly because of the heart’s unique environment.

The heart’s cells are highly specialized and don’t divide regularly, unlike cells in other parts of the body. This means there’s less opportunity for the genetic mutations that can lead to cancer.

Treatment for heart cancer typically involves surgery to remove the tumor, possibly followed by chemotherapy or radiation therapy to target any remaining cancer cells. However, treating heart cancer is challenging.

The heart’s critical function and the complexity of its structure make surgery difficult. Moreover, the effectiveness of chemotherapy and radiation therapy can be limited.

Despite its rarity, the study of heart cancer is important. It helps researchers understand more about how cancers form and spread, potentially leading to breakthroughs in treating more common types of cancer.

Ongoing research and advances in medical technology are improving the diagnosis and treatment of heart cancer, offering hope to those affected by this rare disease.

In summary, while heart cancer is extremely rare, it’s a serious condition that poses significant challenges in terms of diagnosis and treatment.

The rarity of heart cancer underscores the importance of research and the need for advances in medical science to improve outcomes for those affected by this and other types of cancer.

Remember, heart health is vital, so regular check-ups and a healthy lifestyle are key to preventing heart disease and identifying potential problems early.

If you care about heart failure, please read studies about diabetes drug that could revolutionize heart failure treatment, and this drug can be a low-cost heart failure treatment

For more information about heart health, please see recent studies that exercise in middle age reversed worrisome heart failure, and results showing this drug combo can cut risk of stroke and heart attack by half.

Copyright © 2024 Knowridge Science Report. All rights reserved.